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Abstract
Eight density functionals, CAM-B3LYP, LC-ωPBE, M11, MN12SX, N12SX,
ωB97, ωB97X, and ωB97XD, in connection with the Def2TZVP basis set were
assessed together with the SMD solvation model for the calculation of the molecular
and chemical reactivity properties of the angiotensin II vasoconstrictor octapeptide
in the presence of water. All the chemical reactivity descriptors for the systems
were calculated via conceptual density functional theory (CDFT). The potential
bioavailability and druggability as well as the bioactivity scores for angiotensin II
were predicted through different methodologies already reported in the literature
which have been previously validated during the study of different peptidic
systems.
Keywords: angiotensin II, conceptual DFT, chemical reactivity, drug-likeness
features, bioactivity scores
1. Introduction
In order to consider peptides and related compounds as the starting point for the
development of medical drugs, it is mandatory to acquire a knowledge about their
chemical reactivity properties as well as the bioactivity associated with them. From
the basics of medicinal chemistry, it is known that drugs exert their effect by
interacting with the active site of a receptor which is generally a protein [1]. These
interactions rely on the different kinds of bindings between the pharmacophore and
the chemical groups present in the active site and thus intimately related to their
chemical reactivity from a molecular perspective [2, 3]. One of the most powerful
tools to understand the chemical reactivity of interacting molecular systems within
computational chemistry is probably the conceptual density functional theory
(CDFT) [4, 5], also called chemical reactivity theory, which allows to accomplish
this task by resorting to several global and local descriptors which are in turn related
to variations in the electronic densities of the studied systems.
On the basis of the previous considerations, the objective of this work is to study
the chemical reactivity of an octapeptide known as angiotensin II that acts
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constricting the blood vessels and retaining the fluid in the kidneys [1], using the
techniques of the conceptual DFT, determining their global reactivity properties,
that is, of the molecule as a whole. Moreover, during the process of the development
of new drugs, there is a need to learn about the drug-like properties of the involved
molecular systems [6]. Thus, the descriptors of bioavailability and bioactivity
(bioactivity scores) will be calculated through different procedures described in
the literature [7, 8] trying to relate them with the calculated conceptual DFT
descriptors.
2. Computational methodology
In the same way as we have proceeded in our recent studies [9–16], the compu-
tational tasks in this work have been done by considering the popular Gaussian 09
software [17]. Following the conclusions obtained from those studies, eight density
functionals have been chosen, CAM-B3LYP, LC-ωPBE, M11, MN12SX [18], N12SX,
ωB97, ωB97X, and ωB97XD, because they can be considered to be well-behaved for
our purposes according to our proposed KID (for Koopmans in DFT) criteria
[19–23] related to the approximate validity of the Koopmans’ theorem within DFT
[19–23]. For the calculation of the electronic properties, several model chemistries
have been considered, based on the mentioned density functionals in connection
with the Def2TZVP basis set, while a smaller Def2SVP was considered for the
prediction of the most stable structures [24, 25]. In order to obtain accurate results,
all calculations were performed using water, which is the universal biological sol-
vent, simulated with the SMD model [26].
3. Results and discussion
The molecular structures of the conformers of the angiotensin II vasoconstrictor
octapeptide graphically presented in Figure 1 were optimized in the gas phase by
means of the DFTBA model available in the software and then reoptimized with the
eight density functionals described previously, the Def2SVP basis set, and water as
the solvent. The calculation of the electronic properties was performed by using the
same model chemistries but changing the basis set with the Def2TZVP one.
In order to verify the fulfillment of our proposed KID procedure, it is necessary
to perform a comparison of the orbital energies with the results obtained by means
of the vertical I and A through the ΔSCF criterium. To this end, the three main
descriptors are linked by εH with I, εL with A, and their behavior in describing
the HOMO-LUMO gap as JI ¼ ∣εH þ Egs N  1ð Þ  Egs Nð Þ∣,
Figure 1.
Graphical sketch of the angiotensin II molecule.
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JA ¼ ∣εL þ Egs Nð Þ  Egs N þ 1ð Þ∣, and JHL ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
JI
2 þ JA
2
p
. Another descriptor, ΔSL
(the difference between the SOMO and the LUMO), was also designed to guide in
verifying the accuracy of the approximation [9–15]. The results of this analysis are
presented in Table 1.
The overall conclusion that can be extracted from the inspection of the results
presented in Table 1 is that, in agreement with our previous studies on melanoidins
and peptides, the model chemistries involving the MN12SX and N12SX density
functionals are the best for verifying our proposed criteria of well-behavior.
3.1 Calculation of the global reactivity descriptors
By taking into account the KID procedure presented in our previous works
together with the finite difference approximation, the global reactivity descriptors
can be expressed as
Electronegativity χ ¼  12 I þ Að Þ≈
1
2 εL þ εHð Þ [4, 5]
Global hardness η ¼ I  Að Þ≈ εL  εHð Þ [4, 5]
Electrophilicity
ω ¼ μ
2
2η ¼
IþAð Þ2
4 IAð Þ ≈
εLþεHð Þ
2
4 εLεHð Þ
[27]
Electrodonating power
ω
 ¼ 3IþAð Þ
2
16 IAð Þ ≈
3εHþεLð Þ
2
16η
[28]
Electroaccepting power
ω
þ ¼ Iþ3Að Þ
2
16 IAð Þ ≈
εHþ3εLð Þ
2
16η
[28]
Net electrophilicity Δω ¼ ωþ  ωð Þ ¼ ωþ þ ω [29]
Eo E+ E HOMO LUMO
CAM-B3LYP 1887.465 1887.246 1887.489 7.462 0.828
LC-wBPE 1887.192 1886.966 1887.223 8.786 1.767
M11 1887.317 1887.090 1887.345 8.601 1.582
MN12SX 1886.668 1886.440 1886.699 6.164 0.832
N12SX 1887.505 1887.288 1887.531 5.881 0.679
ωB97 1888.093 1887.871 1888.118 8.658 1.890
ωB97X 1887.933 1887.711 1887.959 8.474 1.724
ωB97XD 1887.814 1887.592 1887.840 8.087 1.374
SOMO JI JA JHL ΔSL
CAM-B3LYP 2.205 1.497 1.498 2.117 3.033
LC-wBPE 3.509 2.635 2.619 3.715 5.276
M11 3.124 2.412 2.333 3.356 4.706
MN12SX 0.869 0.021 0.017 0.028 0.038
N12SX 0.785 0.000 0.053 0.053 0.106
ωB97 3.303 2.619 2.575 3.673 5.192
ωB97X 3.144 2.432 2.410 3.424 4.868
ωB97XD 2.809 2.059 2.073 2.922 4.183
Table 1.
Total electronic energies of angiotensin II (in au) for the neutral and charged species, the corresponding orbital
energies (in eV), and the KID-related descriptors obtained with the five density functionals, the Def2TZVP
basis set, and water as the solvent.
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where I is the ionization potential and A the electronic affinity, while εH and εL
are the energies of the HOMO and LUMO, respectively.
The results for the global reactivity descriptors for the angiotensin II octapeptide
based on the values of the HOMO and LUMO energies calculated with the MN12SX
and N12SX density functionals are presented in Table 2.
As expected from the molecular structure of this peptide, its electrodonating
ability is more important that its electroaccepting character. It can be seen that
MN12SX and N12SX density functionals (which verify the KID criteria) give results
different than those obtained from the calculation with the other three density
functionals.
3.2 Bioactivity scores
The molecular properties that are related to the concept of drug-likeness and in
particular those associated with the criteria proposed by Lipinski et al. [30, 31] for
the prediction of oral bioavailability have been calculated by feeding the
corresponding SMILES notations into the Molinspiration software readily available
online (Slovensky Grob, Slovak Republic: https://www.mol inspiration.com). The
results are presented in Table 3.
However, what the Lipinski’s rule of five really measures is the oral bioavailabil-
ity of a potential drug because this is the desired property for a molecule having
drug-like character. Then, a different approach was followed by considering simi-
larity searches in the chemical space of compounds with structures that can be
Electronegativity (χ) Chemical hardness (η) Electrophilicity (ω)
MN12SX 3.3286 4.9685 1.1150
N12SX 3.1472 4.7664 1.0391
Electrodonating power
(ω)
Electroaccepting power
(ωþ)
Net electrophilicity
(Δω)
MN12SX 2.4725 1.1286 3.6011
N12SX 2.3225 1.0468 3.3693
Table 2.
Global reactivity descriptors for the angiotensin II molecule calculated with the MN12SX and N12SX density
functionals with the Def2TZVP basis set and the SMD solvation model using water as the solvent.
Molecule Angiotensin II
miLogP 3.91
TPSA 406.33
nAtoms 75
nON 25
nOHNH 16
nviol 3
nrotb 30
volume 955.57
MW 1046.20
Table 3.
Molecular properties of the angiotensin II peptide calculated to verify the Lipinski’s rule of five.
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compared to those that are being studied and with known pharmacological proper-
ties. The same software was used for the calculation of the bioactivity scores which
are a measure of the ability of the potential drug to interact with the different
receptors, that is, to act as GPCR ligands or kinase inhibitors, to perform as ion
channel modulators, or to interact with enzymes and nuclear receptors. The values
of the bioactivity scores for angiotensin II are presented in Table 4.
These bioactivity scores for organic molecules can be interpreted as active
(when the bioactivity score > 0), moderately active (when the bioactivity score lies
between 5.0 and 0.0), and inactive (when the bioactivity score < 5.0). The
angiotensin II peptide was found to be moderately bioactive toward the protease
inhibitor and the GPCR ligand considered in the study.
4. Conclusions
In this chapter we have presented a new study performed on the chemical
reactivity of the angiotensin II vasoconstrictor octapeptide based on the conceptual
DFT as a tool to explain the molecular interactions.
The knowledge of the values of the global descriptors of the molecular reactivity
of angiotensin II could be useful in the development of new drugs based on this
compound or some analogs.
Finally, the molecular properties related to bioavailability and drug-likeness
have been predicted using a proven methodology already described in the literature,
and the descriptors used for the quantification of the bioactivity allowed to charac-
terize the studied molecule as being moderately bioactive toward the protease
inhibitor and the GPCR ligand considered in this study.
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Molecule Angiotensin II
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Ion channel modulator 3.74
Kinase inhibitor 3.78
Nuclear receptor ligand 3.85
Protease inhibitor 3.25
Enzyme inhibitor 3.67
Table 4.
Bioactivity scores of the angiotensin II molecule calculated on the basis of GPCR ligand, ion channel modulator,
nuclear receptor ligand, kinase inhibitor, protease inhibitor, and enzyme inhibitor interactions.
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